TVP-1012
TVP-1012/CCT-001
Phase 3 small_molecule completed
Quick answer
TVP-1012 for Parkinson's Disease is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Parkinson's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed